ODN 2336-Type A (human, FITC Conjugate) (VAdv-Ly0049)
| CAT | Size | Price | Quantity | |
|---|---|---|---|---|
| VAdv-Ly0049 |
|
ODN 2336-Type A, human TLR9 agonist, FITC conjugate, oligodeoxynucleotide vaccine adjuvant.
Datasheet
Specifications
Type
CpG
Specificity
TLR9 agonist
Product Form
Powder
Percentage
≥ 95%
Endotoxin
Lower than 2 EU/mg.
Storage
Store at -20°C.
Shelf Life
1 year.
Adjuvant Information
Introduction
ODN 2336 is a type A human TLR9 agonist. Class A of ODN stimulate the production of large amounts of Type I interferons, induce the maturation of pDCs. They are also strong activators of NK cells through indirect cytokine signaling.
Sequence
5'-gggGACGACGTCGTGgggggg-FITC (21 mer)
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
